Edmond de Rothschild Private Equity logo

Edmond de Rothschild Private Equity

Europe, Ile-de-France, France, Paris

Description

The Edmond de Rothschild Group is a leader in private equity.

Investor Profile

Edmond de Rothschild Private Equity has made 20 investments, with 2 in the past 12 months and 25% as lead.

Stage Focus

  • Series B (20%)
  • Series C (15%)
  • Series A (15%)
  • Private Equity (15%)
  • Debt Financing (10%)
  • Series Unknown (10%)
  • Post Ipo Debt (10%)
  • Post Ipo Equity (5%)

Country Focus

  • Switzerland (25%)
  • France (25%)
  • Germany (15%)
  • United States (15%)
  • United Kingdom (10%)
  • Italy (5%)
  • The Netherlands (5%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Medical
  • Biopharma
  • Internet
  • Therapeutics
  • Manufacturing
  • Energy
  • Energy Management
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Edmond de Rothschild Private Equity frequently co-invest with?

BioMedPartners
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
VI Partners
Europe, Schwyz, Switzerland, Altendorf
Co-Investments: 1
Index Ventures
North America, California, United States, San Francisco
Co-Investments: 3
Forbion Capital Partners
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 3
Andera Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 7
Neomed Management
Europe, Oslo, Norway, Oslo
Co-Investments: 1
Vesalius Biocapital Partners
Europe, Luxembourg, Luxembourg, Strassen
Co-Investments: 1
EMBL Ventures
Europe, Baden-Wurttemberg, Germany, Heidelberg
Co-Investments: 2
Eclosion SA
Europe, Geneve, Switzerland, Geneva
Co-Investments: 1

Which angels does Edmond de Rothschild Private Equity often collaborate with?

NB
Europe, Basel-Stadt, Switzerland, Basel
Shared Deals: 1

What are some of recent deals done by Edmond de Rothschild Private Equity?

Hippocrates

Milan, Lombardia, Italy

Hippocrates is an Italian independent pharmacy platform with a network of over 120 owned pharmacies.

BeautyHealth CareInformation TechnologyInternetMedicalPharmaceutical
Debt FinancingMar 21, 2025
Amount Raised: $380,683,054
BE WTR

Lausanne, Vaud, Switzerland

BE WTR makes a variety of hygienic water taps for offices and other businesses.

Food and BeverageResidentialWaterWater Purification
Series COct 7, 2024
Amount Raised: $45,637,521
Oncodesign Services

Dijon, Bourgogne, France

Oncodesign Services specializes in drug discovery and preclinical services.

BiotechnologyMedical
Private EquityJan 23, 2024
Amount Raised: $23,886,612
Voltalis

Paris, Ile-de-France, France

Voltalis is an aggregation platform that connected energy saving solutions.

InternetSoftware
Private EquityMar 6, 2023
Amount Raised: $97,247,573
North Star

Aberdeen, Aberdeen City, United Kingdom

North Star is an operator of specialised vessels that offer emergency response and rescue and essential offshore wind maintenance services.

Marine TechnologyService Industry
Debt FinancingDec 6, 2022
Amount Raised: $169,858,181
Française de l'Energie

Forbach, Lorraine, France

Française de l'Energie engages in the exploration and evaluation of gas resources in France.

EnergyEnergy ManagementMiningOil and Gas
Post Ipo DebtOct 3, 2022
Amount Raised: $19,667,172
Française de l'Energie

Forbach, Lorraine, France

Française de l'Energie engages in the exploration and evaluation of gas resources in France.

EnergyEnergy ManagementMiningOil and Gas
Post Ipo DebtSep 27, 2021
Amount Raised: $46,784,118
Swiss Summit Capital

London, England, United Kingdom

Swiss Summit Capital uses a pattern recognition algorithm to provide timely stock market opportunities to your inbox.

Financial Services
Series AApr 5, 2019
Amount Raised: $23,698,223
Philogeris Group

Paris, Idaho, United States

Philogeris is a operating accommodation facility for dependent elderly people.

FitnessHealth CareWellness
Series UnknownOct 1, 2017
Complexa

Pittsburgh, Pennsylvania, United States

Complexa, a biopharmaceutical company, develops therapies for the treatment of inflammatory, and metabolic diseases.

BiotechnologyHealth CareTherapeutics
Series CJul 26, 2017
Amount Raised: $62,000,000